한국어
English
日本語
中文(简体)
Verecbrutib Tablets 80mg (Tirabrutinib Hydrochloride)
86.42mg
Tablet · Prescription medication
Korea Ono Pharmaceutical Co., Ltd.
Tirabrutinib Hydrochloride is a targeted antineoplastic agent used for the treatment of certain blood cancers.
MFDS ingredient code M281650
Tirabrutinib Hydrochloride is a targeted antineoplastic agent used in the treatment of blood cancers, primarily for specific malignancies such as non-Hodgkin lymphoma. This agent belongs to the class of Bruton's tyrosine kinase (BTK) inhibitors and is used to disrupt the growth and survival of cancer cells.
Tirabrutinib Hydrochloride blocks the activity of an enzyme called BTK within cancer cells, thereby interrupting the signaling that allows cancer cells to proliferate and survive. This helps to inhibit the growth of cancer cells and promote their death.
Approved uses differ by product. Check each product's information for its actual use.
Tirabrutinib Hydrochloride is characterized by its higher selectivity compared to other BTK inhibitors, which reduces side effects and enhances treatment efficacy. It also has a specialized mechanism of action tailored for the treatment of blood cancers, making it suitable for specific patient populations.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.